News Image

Vivos Therapeutics Reports Second Quarter 2025 Financial Results and Provides Operational Update

Provided By GlobeNewswire

Last update: Aug 19, 2025

Quarter highlighted by the key acquisition of The Sleep Center of Nevada, which is generating revenue and seeing strong patient demand for Vivos’ differentiated array of highly effective OSA treatments

Read more at globenewswire.com

VIVOS THERAPEUTICS INC

NASDAQ:VVOS (11/3/2025, 8:00:02 PM)

After market: 2.4984 +0.03 (+1.15%)

2.47

-0.11 (-4.26%)



Find more stocks in the Stock Screener

Follow ChartMill for more